Nalaganje...
CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors
Carcinoembryonic antigen T cell bispecific antibody (CEA TCB) is a bispecific antibody used to recognize CEA and CD3e via a novel molecular format (2:1) that induces T cell-mediated killing of CEA over-expressing tumors while sparing primary cells with low CEA expression. CEA TCB treatment inhibits...
Shranjeno v:
| izdano v: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007959/ https://ncbi.nlm.nih.gov/pubmed/27622073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1203498 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|